Collegium Pharmaceutical, Inc.
COLL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $32 | $12 | $2 | $13 |
| Dep. & Amort. | $57 | $57 | $57 | $57 |
| Deferred Tax | -$12 | -$3 | -$1 | -$10 |
| Stock-Based Comp. | $0 | $11 | $12 | $8 |
| Change in WC | -$9 | -$6 | -$16 | $17 |
| Other Non-Cash | $11 | $2 | $1 | $1 |
| Operating Cash Flow | $78 | $72 | $55 | $85 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$45 | -$17 | -$26 | -$27 |
| Inv. Sales/Matur. | $15 | $14 | $17 | $16 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$31 | -$3 | -$10 | -$12 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$16 | -$16 | -$16 | -$16 |
| Stock Issued | $2 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$25 | $0 | -$25 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | -$7 | -$9 | -$0 |
| Financing Cash Flow | -$15 | -$48 | -$25 | -$41 |
| Forex Effect | -$0 | $0 | $0 | $0 |
| Net Chg. in Cash | $33 | $21 | $20 | $32 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $137 | $117 | $97 | $65 |
| End Cash | $170 | $138 | $117 | $97 |
| Free Cash Flow | $78 | $72 | $55 | $84 |